Outsourced Pharma attended the ADC Capabilities Update hosted by Catalent to learn about the integrated ADC and bioconjugate development platform spanning the full product lifecycle.
Public source
Publisher name
Public post
Join Dominick Yeo at the ADC Capabilities Update to learn more about Catalent's integrated ADC and bioconjugate development platform spanning the full product lifecycle,…
Company
Outsourced Pharma
Strategic intelligence for biopharma executives navigating outsourced drug development, manufacturing, and operations.
- Industry
- Pharmaceutical Manufacturing
- Location
- Erie, US
- Company size
- 2–10 employees
About Outsourced Pharma
Outsourced Pharma is built for biopharma and pharma executives who make outsourcing decisions: development leads, manufacturing directors, and operations executives evaluating CDMO, CRO, and CMO partners across the drug development lifecycle. We cover contract manufacturing, clinical outsourcing, regulatory strategy, supplier relationships, and the strategic and operational decisions that determine whether outsourcing works. Our editorial goes beyond vendor directories and press releases - we surface the intelligence that experienced operators actually need. Follow Outsourced Pharma for expert perspectives, in-depth editorial, and industry events, or join the community at https://www.outsourcedpharma.com/
See moreLatest activity
Latest activity from Outsourced Pharma
6 signals
Research & Knowledge
Outsourced Pharma published an article by Arnaud Deladeriere, Ph.D., in collaboration with Cell&Gene Foundry, discussing cell therapy developers' lack of full product understanding.
Legal & Regulatory
Outsourced Pharma noted that the Bloomington, Indiana facilities owned by Catalyst until sold to Novo Nordisk in December 2024 have not solved its quality issues, as confirmed by the FDA in April.
Presence & Recognition
Outsourced Pharma Deputy Editor Jeffrey S. Buguliskis sat down with Krishnan Ramanathan, CEO of the Gates Medical Research Institute, to discuss global health drug development and sustainable manufacturing.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Catalent
Catalent is attending the Advanced Therapies Europe conference to discuss technologies and strategies addressing AAV manufacturing challenges.
Presence & Recognition
Adare Pharma Solutions
Adare Pharma Solutions is participating in Fierce Pharma Manufacturing Day on September 29 to share insights on the challenges, trends, and opportunities shaping the future of biopharma manufacturing.
Presence & Recognition
WuXi XDC
WuXi XDC is hosting a webinar titled Critical Success Factors for ADC Conjugation Process Transfer-Insights from Real-World Case Studies on September 16, 2026.
Presence & Recognition
Simtra BioPharma Solutions
Simtra BioPharma Solutions presented its Special Edition Capability Update at CPHI Milan ahead of the event.
Presence & Recognition
Asymchem Group